Shu J, Yang J. Pediatric endoscopic retrograde cholangiopancreatography: A systematic review of indications, technical success, adverse events, and complication prevention. World J Gastrointest Endosc 2026; 18(9): 125072 [DOI: 10.4253/wjge.125072]
Evaluation of a Journal’s Credibility by Authors
The purpose of an author’s evaluation of a journal’s credibility is to assess the degree of satisfaction with the manuscript editing and publishing process. This evaluation is for user’s reference only.
1 Are you satisfied with the online submission system?
Yes
2 Are you satisfied with the peer review report?
Yes
3 Are you satisfied with the editing quality of the article?
Yes
4 Are you satisfied with the article PDFs?
Yes
5 Are you satisfied with the online full-text article?
Yes
6 Are you satisfied with the prepared figures in the online full-text article?
Yes
7 Are you satisfied with the prepared tables in the online full-text article?
Yes
8 Are you satisfied with the published articles processes?
Yes
9 Are you satisfied with the requirement for providing academic rules and norms?
Yes
10 Are you satisfied with the academic misconduct detection report?
Yes
11 Are you satisfied with the period of publication?
Yes
12 Are you satisfied with the editing and publishing rules and norms?
Yes
Evaluation of a Journal’s Peer Review by Authors
The purpose of an author’s evaluation of a given journal’s peer review is to assess the degree of satisfaction with the peer review process. This evaluation is for user’s reference only.
1 Are you satisfied with the time spent for peer review?
Yes
2 Are you satisfied with the anonymous peer review process?
Yes
3 Is the peer review report of great help to your manuscript?
Yes
4 Do you think the peer review report for your manuscript is fair or objective?
Yes
Author‘s Comments
Author comment — Shu J, Yang J. Pediatric endoscopic retrograde cholangiopancreatography: A systematic review of indications, technical success, adverse events, and complication prevention. World J Gastrointest Endosc 2026; 18(9): 125072.
Pediatric ERCP has quietly shifted from a diagnostic curiosity to a mainstream therapeutic procedure, yet the evidence guiding it remains scattered across small single-center series that define technical success, adverse events, and—above all—post-ERCP pancreatitis (PEP) in incompatible ways. Rather than force these studies into a single pooled estimate, we synthesized 128 reports (2017–2026, 79% published since 2020) descriptively, keeping every outcome tied to its own denominator.
The resulting picture is reassuring but incomplete. In contemporary series, study-level technical success was high (median 94.7%), and PEP remained the principal procedure-related adverse event (median 5.2%; median overall adverse-event rate 8.9%). Indications are dominated by pancreatitis or pancreatic-duct disease and by choledocholithiasis, and most procedures are now therapeutic.
What struck us most is how little of this literature is truly comparable. Sedation and analgesia dosing, radiation metrics, procedure-time definitions, PEP severity grading, and follow-up windows are reported inconsistently or not at all. Until the field adopts standardized pediatric definitions, invests in prospective multicenter registries, and conducts pediatric-specific prevention trials—particularly of rectal NSAIDs and pancreatic-duct stents—reliable benchmarking and genuine pediatric–adult comparison will stay out of reach.
— Jun Shu and Jun Yang, Department of Gastrointestinal Surgery, Wuhan Children's Hospital